| Name | Title | Contact Details |
|---|
Job Match Inc is a Effingham, IL-based company in the Business Services sector.
Arthur G Silk Inc is a Chelsea, MA-based company in the Business Services sector.
Clue Genetics Inc. (Clue) was founded by three life sciences professionals with a proven track record in building successful technology businesses anchored in genome analytics. They have assembled a team with diverse expertise spanning genomics, bioinformatics, microbiology, and analytical chemistry, to execute on Clue`s bold vision to be the leading technology platform for delivering natural product solutions to a broad range of industries. Microbial genomes encode a vast and previously untapped spectrum of natural compounds and enzymes with the potential to address the world`s most pressing problems: new therapies for cancer and age related illnesses, novel antimicrobials to combat debilitating infectious diseases, and environmentally acceptable products to deal with pests and pollution. Clue has secured exclusive access to diverse libraries of microbes, including one of the world`s largest privately held collections of fungi isolated from ecosystems across the entire planet. Clue is applying state-of-the art laboratory techniques and proprietary bioinformatics algorithms to its database of genetic diversity in order to identify novel active compounds and the sets of genes that are needed to make them. By harnessing the power of modern genomics and biotechnology, the company is set to deliver solutions to some of the most critical challenges facing humanity.
Vansen Pharma Inc. is a specialty pharmaceutical company focused on broad therapeutic areas that are anticipated to grow and present an opportunity for major expansion. Vansen will expand its commercial presence by adding complimentary products through in-licensing, co-promotion and acquisitions, resulting in a comprehensive product portfolio. With its US based sales force, Vansen can better serve the increasing healthcare needs of patients and enhance growth. Vansen's current product portfolio of anti-infectives, including Factive®, Spectracef® and Cefditoren Pivoxil®, provides a strong and stable revenue base from which to grow and expand our company. Our experienced management team is aggressively pursuing acquisitions of accretive specialty products, including legacy drugs and cash flow positive healthcare companies. We look forward to executing our growth strategy and creating lasting shareholder value for our investors.
Founded in 1985 by Hal Brierley, Brierley+Partners has a history of creating proven, prominent customer loyalty programs.